Trending Topic

20 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Article highlights There is growing clinical importance attributed to the development of metabolic dysfunction-associated steatotic liver disease in people with type 2 diabetes (T2D). Numerous international groups now advocate screening for advanced fibrosis in people with risk factors, such as T2D, using non-invasive biomarkers. This article explores the rationale to screen for advanced fibrosis in people with risk […]

7 mins

Dan Bessesen, ObesityWeek® 2022: Highlights from the Upcoming Congress

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 17th 2022

touchENDOCRINOLOGY had the pleasure of talking with TOS President Prof Dan Bessesen (UCHealth, University of Colorado, Aurora, CO, USA) around this year’s ObesityWeek®, the key highlights and future Obesity Society activities to look forward to.

Questions

  1. Could you tell us a little about ObesityWeek® and its key themes for 2022? (0:21)
  2. What do you expect to be the highlights of the scientific programme? (2:01)
  3. What other activities can we look forward to from the Obesity Society in 2022? (3:41)
  4. What do you consider the key advances in obesity research in the last year? (5:46)

Disclosures: Dan Bessesen has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup